a. Prostate biopsy cores | |||||
---|---|---|---|---|---|
Characteristic | Controls (N = 67) | Cases (N = 37) | |||
Age (yrs) | 63.66 (8.1, N = 67) | 70.9 (9.0, N = 31) | |||
Race | Â | Â | |||
Black | 3 (4.5%) | 1 (2.7%) | |||
Hispanic | 0 (0%) | 0 (0%) | |||
White | 64 (95.5%) | 19 (51.4%) | |||
Unknown | 0 (0%) | 17 (45.9%) | |||
Number cores available | Â | Â | |||
1 | 10 (14.9%) | 0 (0%) | |||
2 | 56 (83.5%) | 28 (75.7%) | |||
3 | 1 (1.5%) | 4 (10.8%) | |||
4 | 0 (0%) | 5 (13.5%) | |||
Total | 125 | 88 | |||
Number benign cores available | Â | Â | |||
1 | 25 (37.3%) | 29 (78.4%) | |||
2 | 41 (61.2%) | 2 (5.4%) | |||
3 | 0 (0%) | 1 (2.7%) | |||
Number abnormal cores available | Â | Â | |||
1 | 17 (25.4%) | 7 (18.9%) | |||
2 | 0 (0%) | 3(8.1%) | |||
3 | 1 (1.5%) | 0 (0%) | |||
Number cancer cores available | Â | Â | |||
1 | 0 (0%) | 35 (94.6%) | |||
2 | 0 (0%) | 2 (5.4%) | |||
b. Patient characteristics | |||||
Patient status | Attribute | Median | Mean | Std Dev | Range |
Controls | Â | Â | Â | Â | Â |
 | Age (n = 67) | 63.33 | 63.66 | 8.11 | 49.17-86.08 |
 | PSA (n = 66) | 6.22 | 7.3 | 4.651 | 0.09-23.31 |
 | Follow Up In Mos. (n = 67) | 53 | 50.46 | 10.656 | 19-66 |
Cases | Â | Â | Â | Â | Â |
 | Age (n = 31) | 72.17 | 70.77 | 9.025 | 52.33-84.33 |
 | PSA (n = 29) | 5.9 | 6.45 | 2.28 | 2.9-12 |
 | Case Gleason Score (n = 29) | 7 | 7.1 | 0.938 | 6-9 |
 | Core Gleason Score (n = 38) | 6 | 6.53 | 1.269 | 4-9 |
 | % Core Involved (n = 38) | 20 | 23.73 | 18.995 | <1-80 |